HCM · HUTCHMED (China) Limited ADR
United States · RS rating 56 · As of 2026-11-03
| Price | 13.08 USD |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 56 / 38 / 85 / 43 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 45 / 26 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +18.5% |
| Market cap (USD) | $2.4B |